Ceretype Neuromedicine: Funding, Investors & Team (Sep 2026)
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
Ceretype Neuromedicine has raised $2.2M across 1 funding round on record, the most recent a Seed of $2.2M announced in Jan 2024.
That round is below the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Ceretype Neuromedicine Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Ceretype Neuromedicine Funding Rounds
Ceretype Neuromedicine Founders and Leadership Team
No contact details are on record for this team yet.
Ceretype Neuromedicine Funding Compared to Other Artificial Intelligence Startups
Ceretype Neuromedicine's latest round of $2.2M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ceretype Neuromedicine in Artificial Intelligence and Cambridge
Companies Similar to Ceretype Neuromedicine
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Ceretype Neuromedicine Funding FAQs
What does Ceretype Neuromedicine do?
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
How much funding has Ceretype Neuromedicine raised?
Ceretype Neuromedicine has raised $2.2M across 1 round on record. The most recent is a Seed of $2.2M announced in Jan 2024.
When did Ceretype Neuromedicine last raise funding?
Ceretype Neuromedicine's most recent funding round on record is a Seed of $2.2M, announced in Jan 2024.
Who founded Ceretype Neuromedicine?
FundedIQ lists Emily Stern (Founder) at Ceretype Neuromedicine.
Where is Ceretype Neuromedicine headquartered?
Ceretype Neuromedicine is based in Cambridge, Massachusetts, United States.
How many employees does Ceretype Neuromedicine have?
Ceretype Neuromedicine is in the 1-10 employee band.
How does Ceretype Neuromedicine's funding compare to other Artificial Intelligence startups?
Ceretype Neuromedicine's latest round of $2.2M is below the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Ceretype Neuromedicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ceretype Neuromedicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.